A systematic review to evaluate the accuracy of electronic adverse drug event detection

Journal of the American Medical Informatics Association

Volumn 19, Issue 1, 2012, Pages 31-38

  Forster, Alan J ^a,b   Jennings, Alison ^a   Chow, Claire ^a   Leeder, Ciera ^a   van Walraven, Carl ^a,b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SPIRONOLACTONE; WARFARIN;

ACCURACY; ELECTRONIC ADVERSE DRUG EVENT DETECTION; EMBASE; GOLD STANDARD; HUMAN; HYPONATREMIA; INFORMATION SYSTEM; MEDICAL RECORD REVIEW; MEDLINE; PREDICTIVE VALUE; PREVALENCE; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

ALGORITHMS; CLINICAL LABORATORY INFORMATION SYSTEMS; DRUG MONITORING; DRUG TOXICITY; EVALUATION STUDIES AS TOPIC; HUMANS; INFORMATION SYSTEMS; MEDICATION SYSTEMS; PHARMACEUTICAL PREPARATIONS; PHARMACOVIGILANCE;

EID: 84856792845     PISSN: 10675027     EISSN: 1527974X     Source Type: Journal    
DOI: 10.1136/amiajnl-2011-000454     Document Type: Review

References (59)

1. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995;274:29-34.
2. Bates DW, Evans RS, Murff H, et al. Detecting adverse events using information technology. J Am Med Inform Assoc 2003;10:115-28.
3. Thurmann PA, Thurmann PA. Methods and systems to detect adverse drug reactions in hospitals. Drug Saf 2001;24:961-8.
4. Jha AK, Kuperman GJ, Teich JM, et al. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc 1998;5:305-14.
5. Classen DC, Pestotnik SL, Evans RS, et al. Computerized surveillance of adverse drug events in hospital patients. JAMA 1991;266:2847-51.
6. Gandhi TK, Seger DL, Bates DW. Identifying drug safety issues: from research to practice. Int J Qual Health Care 2000;12:69-76.
7. Schiff GD, Klass D, Peterson J, et al. Linking laboratory and pharmacy: opportunities for reducing errors and improving care. Arch Intern Med 2003;163:893-900.
8. Kilbridge PM, Classen DC. Automated surveillance for adverse events in hospitalized patients: back to the future. Qual Saf Health Care 2006;15:148-9.
9. Handler SM, Altman RL, Perera S, et al. A systematic review of the performance characteristics of clinical event monitor signals used to detect adverse drug events in the hospital setting. J Am Med Inform Assoc 2007;14:451-8.
10. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003;289:1107-16.
11. Honigman B, Lee J, Rothschild J, et al. Using computerized data to identify adverse drug events in outpatients. J Am Med Inform Assoc 2001;8:254-66.
12. Al Malaq HM, Al Aqeel SA, Al Sultan MS. Adverse drug reactions related hospitalization identified by discharge ICD-9 codes in a university hospital in Riyadh. Saudi Med J 2008;29:1145-50.
13. Azaz-Livshits T, Levy M, Sadan B, et al. Computerized survelliance of adverse drug reactions in hospital: pilot study. Br J Clin Pharmacol 1998;45:309-14.
14. Bagheri H, Michel F, Lapeyre-Mestre M, et al. Detection and incidence of druginduced liver injuries in hospital: a prospective analysis from laboratory signals. Br J Clin Pharmacol 2000;50:479-84.
15. Brown S, Black K, Mrochek S, et al. RADARx: recognizing, assessing, and documenting adverse Rx events. Proc AMIA Symp 2000;101-5.
16. Brvar MF, Fokker N, Bunc M, et al. The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department specialty. BMC Clin Pharmacol 2009;9:8.
17. Burgess CL, Holman CD, Satti AG. Adverse drug reactions in older Australians, 1981-2002. Med J Aust 2005;182:267-70.
18. Carroll R, McLean J, Walsh M. Reporting hospital adverse events using the Alfred Hospital's morbidity data. Aust Health Rev 2003;26:100-5.
19. Classen DC, Pestotnik SL, Evans RS, et al. Description of a computerized adverse drug event monitor using a hospital information system. Hosp Pharm 1992;27:774, 776-9, 783.
20. Classen DCM, Pestotnik SLM, Evans RSP, et al. Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. JAMA 1997;277:301-6.
21. Dalton-Bunnow MF, Halvachs FJ. Computer-assisted use of tracer antidote drugs to increase detection of adverse drug reactions: a retrospective and concurrent trial. Hosp Pharm 1993;28:746-9, 752-5.
22. Dormann H, Muth-Selbach U, Krebs S, et al. Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting. Drug Saf 2000;22:161-8.
23. Dormann H, Crigee-Rieck M, Neubert A, et al. Implementation of a computerassisted monitoring system for the detection of adverse drug reactions in gastroenterology. Alimen Pharmacol Ther 2004;19:303-9.
24. Egger T, Dormann H, Ahne G, et al. Identification of adverse drug reactions in geriatric inpatients using a computerised drug database. Drugs Aging 2003;20:769-76.
25. Einbinder JS, Scully K. Using a clinical data repository to estimate the frequency and costs of adverse drug events. Proc AMIA Symp 2001:154-8.
26. Evans RS, Pestotnik SL, Classen DC, et al. Development of a computerized adverse drug event monitor. Proc Annu Symp Comput Appl Med Care 1991:23-7.
27. Evans RS, Pestotnik SL, Classen DC, et al. Preventing adverse drug events in hospitalized patients. Ann Pharmacother 1994;28:523-7.
28. Field TS, Gurwitz JH, Harrold LR, et al. Strategies for detecting adverse drug events among older persons in the ambulatory setting. J Am Med Inform Assoc 2004;11:492-8.
29. Gronroos P, Irjala K, Heiskanen J, et al. Using computerized individual medication data to detect drug effects on clinical laboratory tests. Scand J Clin Lab Invest Suppl 1995;222:31-6.
30. Hartis CE, Gum MO, Lederer JW Jr. Use of specific indicators to detect warfarinrelated adverse events. Am J Health Syst Pharm 2005;62:1683-8.
31. Honigman B, Light P, Pulling RM, et al. A computerized method for identifying incidents associated with adverse drug events in outpatients. Int J Med Inform 2001;61:21-32.
32. Hope C, Overhage JM, Seger A, et al. A tiered approach is more cost effective than traditional pharmacist-based review for classifying computer-detected signals as adverse drug events. J Biomed Inform 2003;36:92-8.
33. Huang C, Noirot LA, Reichley RM, et al. Automatic detection of spironolactonedrelated adverse drug events. AMIA Annu Symp Proc 2005:989.
34. Hwang SH, Lee S, Koo HK, et al. Evaluation of a computer-based adverse-drugevent monitor. Am J Health Syst Pharm 2008;65:2265-72.
35. Jha AK, Kuperman GJ, Rittenberg E, et al. Identifying hospital admissions due to adverse drug events using a computer-based monitor. Pharmacoepidemiol Drug Saf 2001;10:113-19.
36. Jha AK, Laguette J, Seger A, et al. Can surveillance systems identify and avert adverse drug events? A prospective evaluation of a commercial application. J Am Med Inform Assoc 2008;15:647-53.
37. Johnstone DM, Kirking DM, Vinson BE. Comparison of adverse drug reactions detected by pharmacy and medical records departments. Am J Health Syst Pharm 1995;52:297-301.
38. Kilbridge PM, Alexander L, Ahmad A. Implementation of a system for computerized adverse drug event surveillance and intervention at an academic medical center. J Clin Outcomes Manage 2006;13:94-100.
39. Kilbridge PM, Campbell UC, Cozart H, et al. Automated surveillance for adverse drug events at a community hospital and an academic medical center. J Am Med Inform Assoc 2006;13:372-7.
40. Koch KE. Use of standardized screening procedures to identify adverse drug reactions. Am J Hosp Pharm 1990;47:1314-20.
41. Kuperman GJ, Teich JM, Bates DW, et al. Representing hospital events as complex conditionals. Proc Annu Symp Comput Appl Med Care 1995:137-41.
42. Levy M, Azaz-Livshits T, Sadan B, et al. Computerized surveillance of adverse drug reactions in hospital: implementation. Eur J Clin Pharmacol 1999;54:887-92.
43. Movig KL, Leufkens HG, Lenderink AW, et al. Association between antidepressant drug use and hyponatraemia: a case-control study. Br J Clin Pharmacol 2002;53:363-9.
44. Nebeker JR, Yarnold PR, Soltysik RC, et al. Developing indicators of inpatient adverse drug events through nonlinear analysis using administrative data. Med Care 2007;45:S81-8.
45. Payne TH, Savarino J, Marshall R, et al. Use of a clinical event monitor to prevent and detect medication errors. Proc AMIA Symp 2000:640-4.
46. Raschke RA, Gollihare B, Wunderlich TA, et al. A computer alert system to prevent injury from adverse drug events: development and evaluation in a community teaching hospital. JAMA 1998;280:1317-20.
47. Seger AC, Jha AK, Bates DW. Adverse drug event detection in a community hospital utilising computerised medication and laboratory data. Drug Saf 2007;30:817-24.
48. Senst BL, Achusim LE, Genest RP, et al. Practical approach to determining costs and frequency of adverse drug events in a health care network. Am J Health Syst Pharm 2001;58:1126-32.
49. Silverman JB, Stapinski CD, Huber C, et al. Computer-based system for preventing adverse drug events. Am J Health Syst Pharm 2004;61:1599-603.
50. Szekendi MK, Sullivan C, Bobb A, et al. Active surveillance using electronic triggers to detect adverse events in hospitalized patients. Qual Saf Health Care 2006;15:184-90.
51. Tavassoli N, Duchayne E, Sadaba B, et al. Detection and incidence of drug-induced agranulocytosis in hospital: a prospective analysis from laboratory signals. Eur J Clin Pharmacol 2007;63:221-8.
52. Tegeder I, Levy M, Muth-Selbach U, et al. Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signals. Br J Clin Pharmacol 1999;47:557-64.
53. Thuermann PA, Windecker R, Steffen J, et al. Detection of adverse drug reactions in a neurological department: comparison between intensified surveillance and a computer-assisted approach. Drug Saf 2002;25:713-24.
54. Tse CS, Madura AJ. An adverse drug reaction reporting program in a community hospital. Qual Rev Bull 1988;14:336-40.
55. van der Hooft CS, Sturkenboom MC, van Grootheest K, et al. Adverse drug reaction-related hospitalisations: a nationwide study in the Netherlands. Drug Saf 2006;29:161-8.
56. Winterstein AG, Hatton RC, Gonzalez-Rothi R, et al. Identifying clinically significant preventable adverse drug events through a hospital's database of adverse drug reaction reports. Am J Health Syst Pharm 2002;59:1742-9.
57. Whipple JK, Quebbeman EJ, Lewis KS, et al. Identification of patient-controlled analgesia overdoses in hospitalized patients: a computerized method of monitoring adverse events. Ann Pharmacother 1994;28:655-8.
58. Lau HS, Florax C, Porsius AJ, et al. The completeness of medication histories in hospital medical records of patients admitted to general internal medicine wards. Br J Clin Pharmacol 2000;49:597-603.
59. Murff HJ, Patel VL, Hripcsak G, et al. Detecting adverse events for patient safety research: a review of current methodologies. J Biomed Inform 2003;36:131-43.